Skip to Main Content

Paper Details

Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
Cancer
39
2018
AR, BRCA2, Cancer, DNA, PTEN, Patients, RNA, SPOP genes, TP53, advanced prostate cancer, bone metastases, formalin, patients, prostate cancer, tumor
Aged, Aged, 80 and over, Bone Neoplasms, Bone and Bones, High-Throughput Nucleotide Sequencing, Humans, Image-Guided Biopsy, Magnetic Resonance Imaging, Male, Middle Aged, Positron-Emission Tomography, Precision Medicine, Prospective Studies, Prostate, Prostatic Neoplasms
Author NameAffiliation
Verena Sailer
Verena SailerCaryl and Israel Englander Institute for Precision Medicine
Marc H Schiffman
Myriam Kossai
Myriam KossaiCaryl and Israel Englander Institute for Precision Medicine
Joanna Cyrta
Joanna CyrtaCaryl and Israel Englander Institute for Precision Medicine
Shaham Beg
Shaham BegCaryl and Israel Englander Institute for Precision Medicine
Brian Sullivan
Bradley B Pua
Kyungmouk Steve Lee
Adam D Talenfeld
David M NanusSandra and Edward Meyer Cancer Center
David M Nanus
Scott T TagawaSandra and Edward Meyer Cancer Center
Scott T Tagawa
Brian D Robinson
Brian D RobinsonCaryl and Israel Englander Institute for Precision Medicine
Rema Rao
Rema RaoCaryl and Israel Englander Institute for Precision Medicine
Chantal Pauli
Chantal PauliCaryl and Israel Englander Institute for Precision Medicine
Rohan BarejaCaryl and Israel Englander Institute for Precision Medicine
Rohan BarejaInstitute for Computational Biomedicine
Luis S BeltranNYU Langone Medical Center
Alexandros SigarasCaryl and Israel Englander Institute for Precision Medicine
Kenneth EngCaryl and Israel Englander Institute for Precision Medicine
Kenneth EngSandra and Edward Meyer Cancer Center
Kenneth Eng
Olivier Elemento
Olivier Elemento
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine
Olivier Elemento
Olivier ElementoCaryl and Israel Englander Institute for Precision Medicine
Olivier ElementoInstitute for Computational Biomedicine
Olivier Elemento
Andrea Sboner
Andrea SbonerInstitute for Computational Biomedicine
Andrea SbonerCaryl and Israel Englander Institute for Precision Medicine
Andrea Sboner
Andrea SbonerCaryl and Israel Englander Institute for Precision Medicine
Andrea SbonerInstitute for Computational Biomedicine
Mark A Rubin
Mark A RubinSandra and Edward Meyer Cancer Center
Mark A RubinCaryl and Israel Englander Institute for Precision Medicine
Mark A Rubin
Mark A RubinCaryl and Israel Englander Institute for Precision Medicine
Mark A RubinSandra and Edward Meyer Cancer Center
  • 1 - 50

Datasets

Release 1.2